Zacks Investment Research, Inc.

Stocksmodernreaders.com

Zacks: Analysts Expect UDR, Inc. (NYSE:UDR) Will Announce Quarterly Sales of $300.64 Million

Wall Street brokerages predict that UDR, Inc. (NYSE:UDR) will post sales of $300.64 million for the current quarter, according to Zacks Investment Research. Seven analysts have issued estimates for UDR’s earnings, with the highest sales estimate coming in at $304.36 million and the lowest estimate coming in at $296.16 million. UDR posted sales of $305.98 million during the same quarter last year, which would indicate a negative year over year growth rate of 1.7%. The business is scheduled to announce its next quarterly earnings report on Tuesday, July 27th.
Picture for Zacks: Analysts Expect UDR, Inc. (NYSE:UDR) Will Announce Quarterly Sales of $300.64 Million
Stocksmodernreaders.com

Zacks Investment Research Lowers Enbridge (NYSE:ENB) to Hold

According to Zacks, “Enbridge has the longest and most sophisticated crude oil and liquids pipeline system in the world that spreads across 17,127 miles. With significant portion of its assets being contracted by shippers for long term, the company’s business model is less exposed to market volatility owing to the pandemic. From 2021 to 2023, the midstream player expects C$17 billion in midstream growth capital projects to be executed. Moreover, the company has estimated roughly C$10-billion growth capital projects to be placed into service in 2021. But, the firm’s balance sheet has significant debt exposure. Over the past year, the firm has mostly been yielding lower dividend than the industry. Also, Enbridge's Line 5 is facing severe backlash from environmental groups and Michigan’s governor wants the pipeline to be shut down over spill concerns.”
Picture for Zacks Investment Research Lowers Enbridge (NYSE:ENB) to Hold
Financial Reportsmodernreaders.com

$279.51 Million in Sales Expected for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) This Quarter

Analysts forecast that Neurocrine Biosciences, Inc. (NASDAQ:NBIX) will post sales of $279.51 million for the current quarter, Zacks reports. Eleven analysts have provided estimates for Neurocrine Biosciences’ earnings, with the highest sales estimate coming in at $312.33 million and the lowest estimate coming in at $265.40 million. Neurocrine Biosciences reported sales of $302.40 million in the same quarter last year, which would suggest a negative year over year growth rate of 7.6%. The firm is expected to report its next quarterly earnings report on Monday, August 2nd.
Picture for $279.51 Million in Sales Expected for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) This Quarter
RELATED CHANNELS
Stocksmodernreaders.com

Box, Inc. (NYSE:BOX) Expected to Post Quarterly Sales of $211.57 Million

Analysts predict that Box, Inc. (NYSE:BOX) will post sales of $211.57 million for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for BOX’s earnings. The highest sales estimate is $211.80 million and the lowest is $211.38 million. BOX reported sales of $192.29 million in the same quarter last year, which would suggest a positive year over year growth rate of 10%. The firm is expected to issue its next earnings report on Wednesday, August 25th.
Financial Reportsmodernreaders.com

Zacks: Analysts Anticipate Argo Group International Holdings, Ltd. (NYSE:ARGO) Will Post Quarterly Sales of $493.73 Million

Analysts predict that Argo Group International Holdings, Ltd. (NYSE:ARGO) will announce $493.73 million in sales for the current quarter, according to Zacks. Three analysts have issued estimates for Argo Group International’s earnings. The highest sales estimate is $495.00 million and the lowest is $492.20 million. Argo Group International posted sales of $436.90 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 13%. The business is scheduled to announce its next quarterly earnings report on Monday, August 2nd.
Marketsmodernreaders.com

DiaSorin (OTCMKTS:DSRLF) Raised to Buy at Berenberg Bank

A number of other research firms also recently issued reports on DSRLF. Zacks Investment Research lowered shares of DiaSorin from a hold rating to a strong sell rating in a research note on Thursday, May 20th. Morgan Stanley lowered shares of DiaSorin from an equal weight rating to an underweight rating in a report on Thursday, March 18th. Four equities research analysts have rated the stock with a sell rating and two have given a buy rating to the stock. DiaSorin currently has a consensus rating of Hold and a consensus price target of $210.00.
YOU MAY ALSO LIKE
Financial Reportsmodernreaders.com

Points International Ltd. (NASDAQ:PCOM) Expected to Announce Quarterly Sales of $66.45 Million

Brokerages predict that Points International Ltd. (NASDAQ:PCOM) (TSE:PTS) will post sales of $66.45 million for the current quarter, Zacks reports. Two analysts have provided estimates for Points International’s earnings, with the highest sales estimate coming in at $67.50 million and the lowest estimate coming in at $65.40 million. Points International posted sales of $40.91 million during the same quarter last year, which suggests a positive year over year growth rate of 62.4%. The business is scheduled to issue its next quarterly earnings results on Wednesday, August 11th.
Stocksmodernreaders.com

Principal Financial Group (NASDAQ:PFG) Downgraded by Zacks Investment Research

According to Zacks, “Principal Financial remains focused on fee-based revenue sources, which help it earn steadily and limit its exposure to interest rate. It continues to benefit from strength and leadership in retirement and long-term savings, group benefits and protection in the United States, retirement and long-term savings in Latin America and Asia, and global asset management. The inorganic growth story is impressive with buyouts fortifying its global footprint and adding fee-based businesses. It boasts a solid capital position. Shares have outperformed its industry in the year-to-date period. However, increase in expenses on higher claims and benefits weigh on its margins. Lower return on equity pose financial risk. Also, dilution from acquisition is a potential headwind. Given the low rate environment, it expects adverse impact on demand for income annuities.”
Financial Reportsmodernreaders.com

Zacks: Brokerages Expect AdaptHealth Corp. (NASDAQ:AHCO) Will Announce Quarterly Sales of $575.16 Million

Analysts predict that AdaptHealth Corp. (NASDAQ:AHCO) will post $575.16 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for AdaptHealth’s earnings. The lowest sales estimate is $557.26 million and the highest is $599.12 million. AdaptHealth posted sales of $232.12 million in the same quarter last year, which indicates a positive year-over-year growth rate of 147.8%. The business is expected to report its next earnings results on Tuesday, August 3rd.
Financial Reportsmodernreaders.com

$312.05 Million in Sales Expected for Comstock Resources, Inc. (NYSE:CRK) This Quarter

Brokerages expect Comstock Resources, Inc. (NYSE:CRK) to report $312.05 million in sales for the current quarter, according to Zacks. Four analysts have made estimates for Comstock Resources’ earnings, with the lowest sales estimate coming in at $293.20 million and the highest estimate coming in at $339.00 million. Comstock Resources reported sales of $179.54 million during the same quarter last year, which would suggest a positive year over year growth rate of 73.8%. The business is scheduled to issue its next quarterly earnings report on Wednesday, August 4th.
Marketsmodernreaders.com

Flagstar Bancorp (NYSE:FBC) Rating Increased to Buy at Zacks Investment Research

According to Zacks, “Flagstar Bancorp, Inc. is the holding company for Flagstar Bank, FSB, a federally chartered stock savings bank. Through its retail banking centers and e-commerce distribution channels, Flagstar attracts deposits from the general public. The institution utilizes these deposits, along with other funds garnered from the secondary market, to originate or acquire loans on a nationwide basis. “
Financial Reportsmodernreaders.com

Analysts Expect NOV Inc. (NYSE:NOV) to Announce -$0.12 Earnings Per Share

Equities analysts expect NOV Inc. (NYSE:NOV) to report earnings of ($0.12) per share for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for NOV’s earnings, with the highest EPS estimate coming in at ($0.10) and the lowest estimate coming in at ($0.15). NOV reported earnings of ($0.07) per share during the same quarter last year, which would indicate a negative year over year growth rate of 71.4%. The business is scheduled to issue its next quarterly earnings results after the market closes on Tuesday, July 27th.
Financial Reportsmodernreaders.com

NeoGames S.A. (NASDAQ:NGMS) Expected to Announce Earnings of $0.12 Per Share

Wall Street analysts predict that NeoGames S.A. (NASDAQ:NGMS) will announce earnings of $0.12 per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for NeoGames’ earnings. The lowest EPS estimate is $0.11 and the highest is $0.13. The firm is expected to announce its next earnings results on Thursday, August 12th.
Financial Reportsmodernreaders.com

Zacks: Analysts Expect Benefitfocus, Inc. (NASDAQ:BNFT) Will Post Quarterly Sales of $59.21 Million

Brokerages expect Benefitfocus, Inc. (NASDAQ:BNFT) to announce sales of $59.21 million for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for Benefitfocus’ earnings, with the highest sales estimate coming in at $59.93 million and the lowest estimate coming in at $58.95 million. Benefitfocus posted sales of $62.17 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 4.8%. The company is scheduled to report its next earnings results on Wednesday, August 4th.
Stocksmodernreaders.com

AB SKF (publ) (OTCMKTS:SKFRY) Downgraded by Zacks Investment Research

According to Zacks, “SKF AB engages in the manufacturing of ball and roller bearings, seals, tools for mounting/dismounting bearings, lubricants and measuring/monitoring instruments. It also produces roller bearing steel and other special steels. The Company operates in three divisions: Industrial Division, Service Division and Automotive Division. It also offers products and knowledge-based services comprising hardware and software, consulting, mechanical services, predictive and preventive maintenance, condition monitoring, decision-support systems and performance-based contracts. SKF AB is headquartered in Gothenburg, Sweden. “